about
Advances in Development of New Treatment for LeishmaniasisEfficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trialProtease expression by microorganisms and its relevance to crucial physiological/pathological eventsEffect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survivalEfficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparisonCathepsin B gene disruption induced Leishmania donovani proteome remodeling implies cathepsin B role in secretome regulationReplication attempt: "Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival".Drug resistance in leishmaniasisThe efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major.Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.Leishmaniasis: a review.Potential Challenges of Controlling Leishmaniasis in Sri Lanka at a Disease Outbreak.Evaluation of the Leishmanicidal Activity of Rutaceae and Lauraceae Ethanol Extracts on Golden Syrian Hamster (Mesocricetus auratus) Peritoneal Macrophages.Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.Detection of Leishmania donovani infection using magnetic beads-based serum peptide profiling by MALDI-TOF MS in mice model.The new pyrazolyltetrazole derivative MSN20 is effective via oral delivery against cutaneous leishmaniasisPharmacotherapeutic options for visceral leishmaniasis-current scenario.In vitro effects of Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens on Leishmania major promastigotesPromising therapeutic targets for antileishmanial drugs.rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in SudanEffect of Amphotericin B Nanodisks on Leishmania major Infected Mice.Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquineIn vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral leishmania species.Antileishmanial activity of a linalool-rich essential oil from Croton cajucara.Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles.Delivery strategies for antiparasitics.Use of antimony in the treatment of leishmaniasis: current status and future directions.Adenine aminohydrolase from Leishmania donovani: unique enzyme in parasite purine metabolismCutaneous leishmaniasis: current and future management.In vitro antileishmanial and antimalarial activity of selected plants of NepalDevelopments in diagnosis and antileishmanial drugs.Miltefosine: oral treatment of leishmaniasis.Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro.Adenylosuccinate synthetase and adenylosuccinate lyase deficiencies trigger growth and infectivity deficits in Leishmania donovani.Antimalarial and antileishmanial activities of aroyl-pyrrolyl-hydroxyamides, a new class of histone deacetylase inhibitorsCombination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni.In vivo/In vitro immune responses to L. major isolates from patients with no clinical response to Glucantime.Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice.Increased Abundance of Proteins Involved in Resistance to Oxidative and Nitrosative Stress at the Last Stages of Growth and Development of Leishmania amazonensis Promastigotes Revealed by Proteome Analysis.
P2860
Q28082097-881D0603-F8F2-483C-BABA-2E5394C6C225Q28241775-D4491D4E-A05C-4F9E-BF34-6D1C6C3F66E3Q28477918-758D0C54-EDE9-45BC-BE53-0BCC282A02D5Q28478343-2C2CD3ED-88C7-4291-BE1D-96DCF088F5BCQ28487597-DEFDCB91-8F66-44C6-AF2B-BEC371F1F0ACQ28535124-05ECE27B-2EC3-4F37-99A9-F23A276FC6F3Q28649604-DE93BBF5-3F94-4039-978C-0F916CE78BAFQ29616242-21FD31D5-62D6-46C8-A08D-C75B37171AFFQ33565085-41CAE23D-51BC-4EAF-B75E-4509CA1FAC90Q33637372-4638F903-4348-4B83-B91C-14C1A8172DA5Q33777851-B0A8D1BF-9C0F-42FA-9B36-A15B938FF797Q33786761-515408E1-180A-46D2-9A23-694B9867511AQ33877775-E6143901-7B94-4A06-A7A2-A5283DA3CB69Q33938137-42F17F38-D215-49AA-A956-9BAB3BAAE429Q33995769-4583165C-5834-4788-8A05-B9D1F4622076Q34299143-97A2B8E7-166E-4AB0-B5F4-A58D07047062Q34342651-9D59DECA-54D4-4857-A6D3-33FCCFD3C7B6Q34514152-63A34184-33F7-4BD8-A308-76ECC4A327EDQ34837180-1430A61C-9F08-49B8-8926-DBE68D560068Q34855381-FF406E6F-E0C7-4DF4-9A7B-C846E891F113Q34889020-C58A8AB2-8A6C-47E8-9AB1-25EB43E3E98EQ35005213-B005BC6F-C741-4687-AC9C-F161DC8D6B8BQ35006918-3D0F66CE-E6D4-4D51-9CEC-7525082864B7Q35013732-C8BA7E94-190E-4DF4-AF1A-DFEB4529003AQ35041254-84AFB508-66FC-4C62-9FA2-EA1E4887C6F3Q35056056-7113BFBC-DC66-4DA9-9F28-081585003E05Q35377767-134650E7-0BB9-46F2-9A6B-7AA0833CA314Q35802063-75CA7253-ECC2-41A6-A106-8BDCE47353CFQ35917279-5354BDFD-9DC8-49BF-8D11-455FFBA701B3Q36167211-DB3A4F03-B0E8-415A-861E-CA240A1E5EB0Q36355665-3597D619-27D4-4C73-ABA3-3E5CCB1F4D13Q36441483-C4DAE591-4393-48FB-A41F-2F3DC3FC3465Q36564101-45A9B0BF-EDFF-4F34-B186-899DA863BC3FQ36688430-4E80310D-FB26-43D1-83B9-110D799434CBQ36724945-E9030E06-4542-4820-B459-33C77311719BQ37121428-FA4EB879-2BE2-4052-AB8A-0146499F6B4BQ37152564-FA82D238-AF28-49A6-B7B8-70057CD18153Q37157818-E4759AB1-8C99-4AF1-BB47-E0420D714662Q37204262-A9C5C932-9842-4397-AFEA-63A9747ED125Q37361783-AC7E3A62-995B-4CDE-B855-2905C89DAFE4
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chemotherapy of leishmaniasis.
@ast
Chemotherapy of leishmaniasis.
@en
Chemotherapy of leishmaniasis.
@nl
type
label
Chemotherapy of leishmaniasis.
@ast
Chemotherapy of leishmaniasis.
@en
Chemotherapy of leishmaniasis.
@nl
prefLabel
Chemotherapy of leishmaniasis.
@ast
Chemotherapy of leishmaniasis.
@en
Chemotherapy of leishmaniasis.
@nl
P356
P1476
Chemotherapy of leishmaniasis.
@en
P2093
Simon L Croft
Vanessa Yardley
P304
P356
10.2174/1381612023396258
P577
2002-01-01T00:00:00Z